State Of Wisconsin Investment Board Revance Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

A detailed history of State Of Wisconsin Investment Board transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 56,767 shares of RVNC stock, worth $145,891. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,767

Previous 56,767 -0.0%

Holding current value

$145,891

Previous $145,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $28,793 - $58,202	-12,305 Reduced 17.81%	56,767 $145,000
Q1 2024 May 14, 2024	SELL	$4.65 - $9.31 $178,308 - $357,001	-38,346 Reduced 35.7%	69,072 $339,000
Q4 2023 Feb 12, 2024	BUY	$5.81 - $11.2 $170,732 - $329,123	29,386 Added 37.66%	107,418 $944,000
Q3 2023 Nov 14, 2023	SELL	$11.47 - $25.07 $173,724 - $379,710	-15,146 Reduced 16.25%	78,032 $895,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $493,061 - $750,770	19,962 Added 27.26%	93,178 $2.36 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $148,679 - $285,616	-8,098 Reduced 9.96%	73,216 $2.36 Million
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $179,004 - $299,578	9,771 Added 13.66%	81,314 $1.5 Million
Q3 2022 Nov 14, 2022	SELL	$14.33 - $28.47 $20,176 - $40,085	-1,408 Reduced 1.93%	71,543 $1.93 Million
Q2 2022 Aug 15, 2022	SELL	$11.52 - $20.4 $182,580 - $323,319	-15,849 Reduced 17.85%	72,951 $1.01 Million
Q1 2021 May 17, 2021	SELL	$24.03 - $29.97 $285,957 - $356,643	-11,900 Reduced 11.82%	88,800 $2.48 Million
Q4 2020 Feb 03, 2021	SELL	$23.41 - $28.34 $72,571 - $87,854	-3,100 Reduced 2.99%	100,700 $2.85 Million
Q3 2020 Nov 16, 2020	BUY	$23.23 - $34.3 $234,623 - $346,430	10,100 Added 10.78%	103,800 $2.61 Million
Q2 2020 Aug 12, 2020	SELL	$12.6 - $26.55 $2.21 Million - $4.66 Million	-175,345 Reduced 65.17%	93,700 $2.29 Million
Q1 2020 May 06, 2020	BUY	$12.46 - $27.81 $261,660 - $584,010	21,000 Added 8.47%	269,045 $3.98 Million
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $1.29 Million - $2.24 Million	111,016 Added 81.02%	248,045 $4.03 Million
Q3 2019 Nov 12, 2019	BUY	$10.22 - $14.5 $109,354 - $155,150	10,700 Added 8.47%	137,029 $1.78 Million
Q2 2019 Aug 14, 2019	BUY	$10.67 - $15.49 $587,159 - $852,399	55,029 Added 77.18%	126,329 $1.64 Million
Q1 2019 May 13, 2019	BUY	$15.4 - $20.39 $155,540 - $205,939	10,100 Added 16.5%	71,300 $1.12 Million
Q4 2018 Feb 11, 2019	BUY	$18.06 - $24.96 $7,223 - $9,984	400 Added 0.66%	61,200 $1.23 Million
Q3 2018 Nov 14, 2018	BUY	$23.55 - $30.1 $645,270 - $824,740	27,400 Added 82.04%	60,800 $1.51 Million
Q2 2018 Aug 03, 2018	BUY	$27.45 - $33.35 $422,730 - $513,590	15,400 Added 85.56%	33,400 $917,000
Q3 2017 Nov 01, 2017	BUY	$22.55 - $28.1 $405,900 - $505,800	18,000	18,000 $496,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Revance Therapeutics, Inc. Transaction History